LumiraDx
Transforming community-based healthcare through POC diagnostics & making lab-comparable tests accessible to all
316 employees · est. 2014 · London, United Kingdom
Milestone Pharmaceuticals, Inc.
Headquartered in Montreal, with a growing subsidiary in Charlotte, NC
126 employees · est. 2007 · Montreal, Canada
Milestone Pharmaceuticals, Inc. is the older company (2014 vs 2007); LumiraDx is the larger of the two.
Side-by-Side Comparison
| Metric | LumiraDx | Milestone Pharmaceuticals, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2007 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | Montreal, Canada |
| Employees | ||
| Employees | 316 larger | 126 |
| Industry | ||
| Industry | Health Care, Medical Devices | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | IPO | IPO |
| Total Funding | ||
| Total Funding | $825.47M | $500.10M |
| Funding Rounds | ||
| Funding Rounds | 7 | 11 |
| Services | ||
| Services | In vitro diagnostic products, Point of care systems, Digital healthcare solutions, Assay and detection systems, Consulting and product services | Development of cardiovascular treatments, Clinical investigations, Publication of scientific research, Providing medications for self-treatment |
| Target Customers | ||
| Target Customers | Healthcare professionals, Research institutions, Hospitals and clinics, Pharmacies, Community outreach programs | Patients with episodic cardiovascular conditions, Individuals experiencing PSVT, Individuals experiencing AFib-RVR, Healthcare professionals interested in clinical trials |
| Taxonomy | ||
| Taxonomy | Point-of-Care Diagnostics, Personalised Healthcare, In Vitro Diagnostics, Tissue-Based Cancer Diagnostics, Diabetes Management, Oncology, Infectious Diseases, Digital Connectivity, Clinical Integration, Population Health Management, Patient-Centered Care, Healthcare Innovation, Diagnostic-Led Care, Interoperability | Biopharmaceutical, Clinical-stage, Drug Development, Cardiovascular Indications, Calcium Channel Blocker, Clinical Trial, Atrial Fibrillation, Angina, Phase 3, Etripamil, Nasal Spray, Patient-administered, Montreal-based, NASDAQ-listed |
| Website | ||
| Website | lumiradx.com | milestonepharma.com |
About LumiraDx
LumiraDx, founded in 2014 and headquartered in the United Kingdom, is making significant strides in the healthcare sector by pioneering point-of-care (POC) diagnostics. The company's slogan, "Transforming community-based healthcare through POC diagnostics & making lab-comparable tests accessible to...
About Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Canada, with operations in both Montreal and a growing subsidiary in Charlotte, NC. Established in 2007, Milestone is committed to advancing treatments for cardiovascular conditions. Currently, Milestone...
We will tell you when either one moves
BounceWatch watches LumiraDx and Milestone Pharmaceuticals, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at LumiraDx and Milestone Pharmaceutic... — by email.
Frequently Asked Questions
Compare LumiraDx with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at LumiraDx on 2 Sep 2026, and Milestone Pharmaceuticals, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
